|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 475/04 | |
| A61P 43/00 | |||
| A61P 9/00 | |||
| A61P 25/00 | |||
| A61P 25/16 | |||
| A61P 25/24 | |||
| A61P 7/06 |
| (11) | Number of the document | 2224927 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08781435.6 |
| Date of filing the European patent application | 2008-07-07 | |
| (97) | Date of publication of the European application | 2010-09-08 |
| (45) | Date of publication and mention of the grant of the patent | 2014-08-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/069319 |
| Date | 2008-07-07 |
| (87) | Number | WO 2009/088530 |
| Date | 2009-07-16 |
| (30) | Number | Date | Country code |
| 18735 P | 2008-01-03 | US | |
| 19753 P | 2008-01-08 | US |
| (72) |
KAKKIS, Emil, D., US
|
| (73) |
BioMarin Pharmaceutical Inc.,
105 Digital Drive, Novato, CA 94949,
US
|
| (54) | PTERIN ANALOG FOR TREATING BH4 RESPONSIVE CONDITION |
| PTERIN ANALOG FOR TREATING BH4 RESPONSIVE CONDITION |